26 related articles for article (PubMed ID: 10703730)
21. Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugs.
Nosal R
Cardiovasc Hematol Agents Med Chem; 2006 Jul; 4(3):237-61. PubMed ID: 16842209
[TBL] [Abstract][Full Text] [Related]
22. Nonreceptor interactions in the pharmacology of blood platelets.
Nosál R; Jancinová V
Gen Physiol Biophys; 1999 Oct; 18 Spec No():120-5. PubMed ID: 10703730
[TBL] [Abstract][Full Text] [Related]
23. Role of paf-acether and related ether-lipid metabolism in platelets.
Chignard M; Coëffier E; Benveniste J
Adv Exp Med Biol; 1985; 192():309-26. PubMed ID: 2422886
[No Abstract] [Full Text] [Related]
24. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
Jurasz P; Alonso-Escolano D; Radomski MW
Br J Pharmacol; 2004 Dec; 143(7):819-26. PubMed ID: 15492016
[TBL] [Abstract][Full Text] [Related]
25. Current aspects on human platelet activation and responses.
Steen VM; Holmsen H
Eur J Haematol; 1987 May; 38(5):383-99. PubMed ID: 3115820
[No Abstract] [Full Text] [Related]
26. Are phospholipases involved in platelet activation?
Bereziat G
Agents Actions; 1979 Oct; 9(4):390-9. PubMed ID: 391008
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
